China · Delayed Price · Currency is CNY Sansure Biotech Company Description
Sansure Biotech Inc. researches and develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally.
It offers respiratory tract infections, reproductive tract infections, blood-borne infections, gastrointestinal infections, vector-borne diseases and others, DNA/RNA extraction reagents, sample storage reagent, extraction instruments, PCR instruments, mPOCT.
The company provides nucleic acid extraction or purification kits, multi-type sample DNA/RNA extraction-purification kits, and sample release reagents; sample storage reagents for SARS-CoV-2; extraction instruments and systems; and PCR instruments comprising real-time quantitative thermal cyclers, portable molecule workstations, and real-time PCR systems.
The company was founded in 2008 and is headquartered in Changsha, China.
| Country | China |
| Founded | 2008 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 2,064 |
| CEO | Lizhong Dai |
Contact Details
Address: No. 680, Lusong Road Changsha, 410205 China | |
| Phone | 86 731 8888 3176 |
| Website | sansure.com.cn |
Stock Details
| Ticker Symbol | 688289 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000043J1 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Lizhong Dai | Chairman of the Board and GM |
| Zhu Peng | Chief Financial Officer, Deputy GM and Director |
| Haixiao Wang | Deputy GM and Director |
| Kang Wu | Deputy GM and Director |
| Xiao Mei Ren | Employee Director |
| Qiang Huang | Secretary |
| Zhongping Deng | Deputy General Manager |
| Xiaoyan Xiong | Deputy General Manager |
| De Yong Tan | Deputy General Manager |
| Dr. Keya Zhang | Core Technical Personnel |